TGF-β1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 8, 2000, Pages 2336-2342

  Bochaton Piallat, Marie Luce ^b   Kapetanios, Anastasios D ^b   Donati, Guy ^b   Redard, Mireille ^b   Gabbiani, Giulio ^b   Pournaras, Constantin J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; DESMIN; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITREORETINOPATHY; BIOSYNTHESIS; CONFOCAL MICROSCOPY; ENZYME IMMUNOASSAY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MIDDLE AGED; PATHOLOGY; ULTRASTRUCTURE;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; FIBROBLASTS; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0034218680     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-125.
2. Grierson I, Mazure A, Hogg P, et al. Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction. Eye. 1996;10:671-684.
3. Boulton ME, Foreman D, McLeod D. Vascularised vitreoretinopathy: the role of growth factors Eye. 1996; 10:691-696.
4. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159-165.
5. Weller M, Wiedemann P, Heimann K. Proliferative vitreoretinopathy: is it anything more than wound healing at the wrong place? Int Ophthalmol. 1990;14:105-117.
6. Desmoulière A, Gabbiani G. The role of myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press; 1996:391-423.
7. Skalli O, Schurch W, Seemayer T, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989;60: 275-285.
8. Chiavegato A, Bochaton-Piallat ML, D'Amore E, et al. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Arch. 1995;426:77-86.
9. Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol. 1985;69:810-823.
10. Smiddy WE, Maguire AM, Green WR, et al. Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. Ophthalmology. 1989;96:811-820; discussion 821.
11. Grierson I, Hiscott P, Hogg P, et al. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8:255-262.
12. Walshe R, Esser P, Wiedemann P, et al. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol. 1992;76:550-552.
13. Kon CH, Occleston NL, Aylward GW, et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
14. Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
15. Ronnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts: implications for myofibroblast generation in breast neoplasia. Lab Invest. 1993;68:696-707.
16. Serini G, Bochaton-Piallat ML, Ropraz P, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol. 1998;142:873-881.
17. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
18. Kocher O, Skalli O, Bloom WS, et al. Cytoskeleton of rat aortic-smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest. 1984;50:645-652.
19. Benzonana G, Skalli O, Gabbiani G. Correlation between the distribution of smooth muscle or non muscle myosins and α-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton. 1988;11:260-274.
20. Borsi L, Carnemolla B, Castellani P, et al. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol. 1987;104:595-600.
21. Xu G, Redard M, Gabbiani G, et al. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol. 1997;151:1741-1749.
22. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549-550.
23. Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology. 1987;94:327-332.
24. Majno G, Gabbiani G, Hirschel BJ, et al. Contraction of granulation tissue in vitro: similarity to smooth muscle Science. 1971;173: 548-550.
25. Gabbiani G, Hirschel BJ, Ryan GB, et al. Granulation tissue as a contractile organ: a study of structure and function. J Exp Med. 1972;135:719-734.
26. Harris AK, Stopak D, Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature. 1981;290:249-251.
27. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994;124:401-404.
28. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986;261:4337-4345.
29. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83:4167-4171.
30. Serini G, Gabbiani G. Modulation of α-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: an in vivo and in vitro study. Wound Rep Reg. 1996;4:277-287.
31. Immonen I, Tervo K, Virtanen I, et al. Immunohistochemical demonstration of cellular fibronectin and tenascin in human epiretinal membranes. Acta Ophthalmol (Copenh). 1991;69:466-471.
32. Rubbia-Brandt L, Sappino AP, Gabbiani G. Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Mol Pathol. 1991;60: 73-82.
33. Vyalov S, Desmouliere A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch B Cell Pathol Mol Pathol. 1993;63:231-239.
34. Xing Z, Tremblay GM, Sime PJ, et al. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-β1 and myofibroblast accumulation. Am J Pathol. 1997;150:59-66.
35. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999;250:273-283.
36. Singer, II, Kawka DW, Kazazis DM, et al. In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol. 1984;98:2091-2106.
37. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol. 1992;36:373-384.
38. Grabner G, Boltz G, Forster O. Macrophage-like properties of human hyalocytes. Invest Ophthalmol Vis Sci. 1980;19:333-340.
39. Hiscott PS, Grierson I, Trombetta CJ, et al. Retinal and epiretinal glia: an immunohistochemical study. Br J Ophthalmol. 1984;68: 698-707.
40. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1990;31:14-28.
41. Skalli O, Pelte MF, Peclet MC, et al. α-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem. 1989; 37:315-321.
42. Ronnov-Jessen L, Petersen OW, Koteliansky VE, et al. The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest. 1995;95:859-873.